Rationale Exacerbations are key drivers of morbidity and mortality in chronic obstructive pulmonary disease (COPD).Objectives We compared the relative efficacy of the long-acting inhaled bronchodilator/antiinflammatory combination (salmeterol/fluticasone propionate) 50/500 microg twice daily and the...
No comments yet
Be the first to share your thoughts!